Fábio Ribeiro Queiroz

Fábio Ribeiro Queiroz

Auto-generated profile, based on publicly available information

Fábio Ribeiro Queiroz

Laboratório de Pesquisa Translacional em Oncologia, Instituto Mário Penna, 30380-490 Belo Horizonte, MG, Brasil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IAIzabela Ferreira Gontijo de Amorim
Izabela Ferreira Gontijo de Amorim
CMCarolina Pereira de Souza Melo
Carolina Pereira de Souza Melo
RPRamon de Alencar Pereira
Ramon de Alencar Pereira
SCSidnéa Macioci Cunha
Sidnéa Macioci Cunha
TZThalía Rodrigues de Souza Zózimo
Thalía Rodrigues de Souza Zózimo
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
High-grade serous ovarian cancer (HGSOC) low overall survival rate is often attributed to platinum resistance. Recent studies suggest that the tumor associated-microenvironment (TME) is a determining factor in malignant tumor progression and DNA damage plays a crucial role in this process. Here, we sought to identify platinum resistance biomarkers associating the TME immune profile and the mutational landscape of the homologous repair pathway genes with the HGSOC patients prognosis and response to chemotherapy. Using a decision tree classifier approach, we found that platinum resistant (PR) patients were characterized by the presence of a novel deep intronic variant, the CHEK2 c.319+ 3943A > T, and higher L1 expression (p = 0.016), (100% accuracy). Chek2 protein is an important component of DNA repair and L1, also known as calprotectin, is one component of the neutrophil extracellular traps (NETs) during inflammation, previously suggested as a key contributor to the metastatic process in HGSOC. Also, PD-L2 levels were significantly higher in PR patients positive for this CHEK2 variant (p = 0.048), underscoring the need to explore its potential therapeutic role for this cancer. Our results suggest an interplay between TME and DNA repair variants that results in a multifactorial nature of HGSOC resistance to platinum chemotherapy.

20 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
DCDiogo Gomes da Costa
Diogo Gomes da Costa
FQFábio Ribeiro Queiroz
Fábio Ribeiro Queiroz
FOFlávia Santiago de Oliveira
Flávia Santiago de Oliveira
ANAngelo Borges de Melo Neto
Angelo Borges de Melo Neto
MSMarina Malheiros Araujo Silvestrini
Marina Malheiros Araujo Silvestrini
ADAdriana Dias
Adriana Dias
Background/Objectives: Breast cancer is the most prevalent tumor among women worldwide, with the triple-negative (TNBC) being the most aggressive and therapeutically resistant subtype. It is crucial to investigate new therapeutic targets for the treatment of TNBC. Pentraxin 3 (PTX3), an acute-phase protein, has a complex role in tumor progression, with its expression associated with disease severity. We investigated the role of recombinant human PTX3 (rhPTX3) in modulating microRNA (miRNA) expression and extracellular vesicle (EV) release in TNBC MDA-MB-231 cells. Methods: PTX3 gene expression was evaluated by RT-qPCR. The miRNA expression profile was determined by small RNA Next-Generation Sequencing (NGS). EV release was analyzed by nanoparticle tracking analysis (NTA), flow cytometry, and protein quantification. Results: rhPTX3 treatment significantly increased PTX3 gene expression in MDA-MB-231 cells. Furthermore, rhPTX3 altered the expression profile of 142 miRNAs, with 112 being upregulated and 30 downregulated. These differentially expressed miRNAs were predicted to have 12,894 potential targets, impacting 29 canonical pathways related to carcinogenesis. Key molecules for cancer progression were inhibited (IL6, IL4, CXCL8, CXCR4, CXCL12; ICAM1, CD44 and BCL2), and pro-apoptotic BAD was activated. While rhPTX3-treatment increased total EV release, it specifically reduced the percentage of the CD44+ EV subpopulation. Conclusions: Our data demonstrates that PTX3 modulates the miRNA expression profile and EV release dynamics, particularly by reducing the CD44+ EV population, which points to a tumor-suppressor role in this TNBC context. Given the limited therapeutic avenues for TNBC, our results suggest that PTX3 and its downstream molecular effects represent promising and previously unexplored potential therapeutic targets.

20 September 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
FQFábio Ribeiro Queiroz
Fábio Ribeiro Queiroz
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
CMCarolina Pereira de Souza Melo
Carolina Pereira de Souza Melo
MGMatheus de Souza Gomes
Matheus de Souza Gomes
LALaurence Rodrigues do Amaral
Laurence Rodrigues do Amaral
PSPaulo G.O. Salles
Paulo G.O. Salles
In Brief Queiroz et al. showed that the application of cluster methodology for classifying gastric cancer is suitable and efficient within a Brazilian cohort, which is known for its population heterogeneity. The study highlighted the potential utilization of this method within public health services due to its low-cost, presenting a viable means to improve the diagnosis and prognosis of gastric cancer. Highlights Our Brazilian cohort with gastric cancer has a distinct distribution between mutated and normal p53. New genetic

23 October 2025 in Mário Penna Journal
Verified
Journal Article
Open access
BDBruna Custódio Dias Duarte
Bruna Custódio Dias Duarte
ANAngelo Borges de Melo Neto
Angelo Borges de Melo Neto
ÁCÁlvaro Percínio Costa
Álvaro Percínio Costa
CMCarolina Pereira de Souza Melo
Carolina Pereira de Souza Melo
PSPaulo G.O. Salles
Paulo G.O. Salles
FQFábio Ribeiro Queiroz
Fábio Ribeiro Queiroz
Introduction: Cervical cancer (CC) is one of the most common types of cancer in women and is closely associated with persistent infection by oncogenic types of the human papillomavirus (HPV). The World Health Organization (WHO) aims to eradicate CC as a public health problem by 2100. However, challenges such as vaccination limitations and the spread of misinformation hinder vaccine uptake, despite its proven efficacy (1). The prognosis of CC depends on the stage of the disease and becomes more unfavorable in advanced stages. Therefore, the search for effective biomarkers for diagnosis and monitoring is essential to improve early detection and treatment follow-up. Objectives: This study aimed to explore the role of long non-coding RNAs (lncRNAs) in CC, focusing on identifying and characterizing relevant lncRNAs, understanding their regulatory mechanisms and molecular interactions, and analyzing their expression patterns in patients with different responses to chemoradiotherapy. Methods: A retrospective observational study was conducted, analyzing RNA samples from 31 patients treated at the Mário Penna Institute (2017-2019) (2). The expression of lncRNAs was analyzed by RNA-seq, and molecular interactions were investigated using bioinformatics tools such as AnnoLnc2 and ClusterProfiler. Decision tree analyses and Kaplan-Meier survival curves were performed to assess the association between lncRNAs and clinical outcomes. Results: Among the 417 differentially expressed lncRNAs identified, three stood out: ENSG00000267838, ENSG00000266340, and FRMD6-AS1. High expression of ENSG00000267838 and ENSG00000266340 correlated with treatment resistance and a worse prognosis, while their low expression indicated a better therapeutic response. Kaplan-Meier analysis showed that high expression of these lncRNAs was associated with shorter progression-free survival. The decision tree model demonstrated high accuracy (87.09%) in distinguishing between responder and non-responder patients. Conclusions: Three lncRNAs, ENSG00000267838, ENSG00000266340, and FRMD6-AS1, were identified as being positively associated with non-response to chemoradiotherapy and poorer progression-free survival in CC patients. Specifically, the upregulation of lncRNA ENSG00000267838 was linked to treatment resistance, while its downregulation was associated with a favorable response to chemoradiotherapy.

30 July 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
NCNatália Gregório Custódio
Natália Gregório Custódio
FQFábio Ribeiro Queiroz
Fábio Ribeiro Queiroz
AMAngelo Borges de Melo
Angelo Borges de Melo
BCBrenda Martins Cavalcante
Brenda Martins Cavalcante
LALaurence Rodrigues do Amaral
Laurence Rodrigues do Amaral
WJWander Jeremias
Wander Jeremias
Highlights ■ Two gene groups with contrasting expression profiles were identified. ■ The ATP1B3 and SLCOB3 gene profiles classified patients with 90% accuracy. ■ The ATP1B3 and SLCOB3 gene signature is a potential predictor of treatment response. ABSTRACT Introduction: Cervical cancer is the fourth most common cancer in women worldwide. Resistance to chemoradiotherapy in cervical cancer has been widely associated with membrane transport-related genes, particularly those encoding efflux transport proteins, such as the ATP-binding cassette family members (including P-glycoprotein), which

23 October 2026 in Mário Penna Journal
Verified
Journal Article
Open access
PDF file
DFDayane Freitas
Dayane Freitas
CMCarolina Pereira de Souza Melo
Carolina Pereira de Souza Melo
AGAna Luiza de Freitas Magalhães Gomes
Ana Luiza de Freitas Magalhães Gomes
FQFábio Ribeiro Queiroz
Fábio Ribeiro Queiroz
PSPaulo G.O. Salles
Paulo G.O. Salles
O câncer de mama triplo-negativo (CMTN) é um subtipo agressivo de câncer, caracterizado pela ausência de expressão de receptores de estrógeno, progesterona e HER2, limitando suas opções terapêuticas. O gene repressor transcricional da família spen (SPEN) é considerado um supressor tumoral, participando de vias fundamentais de controle do ciclo celular, como a via Notch e a via de sinalização do estrogênio, na qual atua como modulador negativo deste hormônio por meio da repressão do receptor de estrogênio α (ERα). Ambas as vias estão envolvidas na proliferação e diferenciação celular, fatores importantes para estudos de processos de oncogênese. Estudos mostram que mutações de perda de função do gene SPEN podem estar associadas a uma disfunção no controle do ciclo celular, levando ao início de processos patológicos. Por esta razão, este estudo investigou a hipótese de uma possível associação entre mutações no gene SPEN e a progressão e a ocorrência de metástase no CMTN.